Lyell Immunopharma, Inc. (LYEL) › Weighted Average Diluted SharesLyell Immunopharma, Inc. (LYEL) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2019-12-31: 5.4K2020-12-31: 13.26M2021-12-31: 135.92M2022-12-31: 247.08M2023-12-31: 12.55M2024-12-31: 13.07M2025-12-31: 17.09M17.09M2019-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3117.09M+30.7%2026-03-12From 2025-01-012024-12-3113.07M+4.2%2026-03-12From 2024-01-012023-12-3112.55M-94.9%2026-03-12From 2023-01-012022-12-31247.08M+81.8%2025-03-11From 2022-01-012021-12-31135.92M+925.2%2024-02-28From 2021-01-012020-12-3113.26M+244107.0%2023-02-28From 2020-01-012019-12-315.4K—2022-03-29From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)